Order Article Reprints

Okuda K, Umemura A, Umemura S, Kataoka S, Taketani H, Seko Y, Nishikawa T, Yamaguchi K, Moriguchi M, Kanbara Y, et al. Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis. Cancers. 2021; 13(7):1515. https://doi.org/10.3390/cancers13071515

Okuda, Keiichiro, Atsushi Umemura, Shiori Umemura, Seita Kataoka, Hiroyoshi Taketani, Yuya Seko, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Yoshihiro Kanbara, and et al. 2021. "Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis" Cancers 13, no. 7: 1515. https://doi.org/10.3390/cancers13071515

Okuda, K., Umemura, A., Umemura, S., Kataoka, S., Taketani, H., Seko, Y., Nishikawa, T., Yamaguchi, K., Moriguchi, M., Kanbara, Y., Arbiser, J. L., Shima, T., Okanoue, T., Karin, M., & Itoh, Y. (2021). Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis. Cancers, 13(7), 1515. https://doi.org/10.3390/cancers13071515